BURE EQUITY AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334 SEK | +3.28% |
|
+3.41% | +16.86% |
| 02-22 | Bure Equity AB Proposes Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024 | CI |
| 02-22 | Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | -9.17B -838M -67.1B | Sales 2023 | 4.81B 439M 35.17B | Capitalization | 21.19B 1.94B 155B |
|---|---|---|---|---|---|
| Net income 2022 | -9.24B -845M -67.62B | Net income 2023 | 4.74B 434M 34.71B | EV / Sales 2022 | -1.93 x |
| Net cash position 2022 | 529M 48.35M 3.87B | Net cash position 2023 | 1.57B 144M 11.51B | EV / Sales 2023 | 4.08 x |
| P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
4.47
x | Employees | 10 |
| Yield 2022 |
0.91% | Yield 2023 |
0.87% | Free-Float | 70.61% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.28% | ||
| 1 week | +3.41% | ||
| Current month | -2.57% | ||
| 1 month | +0.54% | ||
| 3 months | +9.72% | ||
| 6 months | +56.51% | ||
| Current year | +16.86% |
1 week
319.40
339.40
1 month
315.20343.80
Current year
272.40346.00
1 year
202.20346.00
3 years
171.30489.20
5 years
126.40489.20
10 years
26.40489.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/12/98 | |
Max Jonson
DFI | Director of Finance/CFO | 56 | 30/09/13 |
| Chairman | 60 | 31/12/98 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 30/04/19 | |
| Chairman | 60 | 31/12/98 | |
| Director/Board Member | 70 | 09/05/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 233 M€ | +8.82% | ||
| 0.01% | 773 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 334 | +3.28% | 25,827 |
| 25/04/24 | 323.4 | -3.64% | 34,434 |
| 24/04/24 | 335.6 | +1.39% | 49,191 |
| 23/04/24 | 331 | +3.05% | 26,030 |
| 22/04/24 | 321.2 | -0.56% | 24,632 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:29 pm
More quotes
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Sector
Investment Holding Companies
Calendar
06/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +16.86% | 2.26B | |
| +16.54% | 75.59B | |
| +53.03% | 16.95B | |
| +3.20% | 15.78B | |
| +7.21% | 13.87B | |
| -0.77% | 12.3B | |
| +9.67% | 12.04B | |
| +6.24% | 10.88B | |
| +34.86% | 10.17B | |
| -1.71% | 9.7B |
- Stock Market
- Equities
- BURE Stock
